BIO Deutschland English News ’s Post

After kicking off November at the Meet the XLEAP workshop in Prague, my next stop was Bratislava! Last week I had the pleasure of joining my Slovak colleagues from GeneTiCA Group to meet experts from MEDIREX GROUP and MEDIXBANK, where we explored the future of laboratory automation and its potential impact on their work. It was a fantastic opportunity to showcase the 𝐆𝐞𝐧𝐞𝐓𝐢𝐂𝐀 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐂𝐞𝐧𝐭𝐫𝐞 and discuss how automation is transforming laboratories and bringing them into the 21st century. 🚀 𝐖𝐡𝐲 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞? It's not just about the high-tech appeal (although it certainly makes the lab look cool!); it's about freeing teams from repetitive tasks, such as NGS library preparation or nucleic acid isolation, that can be prone to costly errors if attention lapses for a moment. By automating these workflows, we can secure valuable samples, reduce errors and save significant time and resources. 🧪🕐 The Illumina TruSight Oncology 500 (TSO 500) assay is a great example. This NGS-based CGP workflow takes around 𝟏𝟎.𝟓 𝐡𝐨𝐮𝐫𝐬 manually, but automation 𝐜𝐮𝐭𝐬 𝐭𝐡𝐚𝐭 𝐝𝐨𝐰𝐧 𝐭𝐨 𝟐.𝟓 𝐡𝐨𝐮𝐫𝐬. That's time saved for high-impact work like data analysis and clinical interpretation, turning routine tasks into meaningful research that drives discovery. 👩🔬👨🔬 If you're curious about advancing your lab workflows through automation, let's connect and explore custom solutions together! #GeneTiCA #GetToKnow #GeneTiCAExperienceCentre #Automation #InnovationInMultiOmics

⚕️ Don’t miss QIAGEN at the AI and Data in Pharma Healthcare Summit in Munich, Germany! Learn how you can leverage our unique blend of expert-curated and generative AI-derived biomedical knowledge, which lets you hit the ground running with drug discovery. Learn more 👇 #BiomedicalKB #DoYouAI

⏰ In about one hour! Join us to hear about the latest updates to our Chemistry42 #generativeAI platform for small molecule design and optimization! Including: #hitID workflows Multi-Parametric #LeadOPT #BindingFreeEnergy predictions #ADMET profile prediction, optimization and model training #Retrosynthesis ...and so much more!

Webinar covering the new version of Chemistry42 and its key features is going live very soon!

The results of R.PRJ are available on bioRxiv demonstrating the reproducibility of Sampling Human’s technology for the highly specific capture of single cells for analysis. Decentralized data collection by independent labs was made possible by our uniquely user-friendly benchtop kit. Key takeaways - 78 assays were conducted by 30 users across 12 distinct laboratories, demonstrating high reproducibility and sensitivity. - First-time users from diverse laboratory environments and proficiency levels were able to consistently discriminate between sample types differing only by 0.001%. - Target cells were accurately identified at concentrations as low as 1 cell per 100,000 background cells. Read the article here: https://lnkd.in/e7jen3Cz

RECORDING & SLIDES POSTED (for DIA members): June 26 #diarim #intelligentautomation meeting where Wim DHaeze, PhD, ELS from Sarepta Therapeutics facilitated a discussion of Adoption of AI-Driven Automation in #rim Systems. Lots of good nuggets and experiences in here about what's working, not working, challenges companies are facing after the proof-of-concept stage, etc. Let me know if you have any questions or would like to discuss further. Slides for DIA members only - https://lnkd.in/ecX6SJWq Recording for DIA members only - https://lnkd.in/eh7mXPtH #ai #automation #regulatory #regops #pharma

Quick reminder that I'll be delivering a keynote at next week's Reuters Pharma EU in Barcelona titled “Pharma’s coming (r)evolution: How we unlock the promise of today’s 'Golden Age for Medicine.'"   With breakthroughs across so many categories thanks to better understanding of science, leaps in genomics and the use of AI in drug discovery, the future of medicine is here. Yet our industry is under unprecedented pressure to demonstrate the value of our therapies versus the prices they command.   So, what's happening? To solve this disconnect, our industry must evolve its approach to customer engagement and partnership to ensure this Golden Age of Medicine translates into the future of health we all want.   I'll be speaking 16 April. #REPharma2024 #pharma #futureofhealth

#Webinar now available on demand! Automated #immunoassayplatforms for enhancing #AAVanalytics Lisa Mutz (Product Manager, PROGEN) and Chris Heger (Director of Applications Science, Bio-Techne) discuss the transformative power of automation in #analyticalAAVtools, introducing unparalleled precision, reproducibility, and consistency. Watch this webinar to: • Discover the significance of top-tier #AAVantibody and protein reagents • Learn how to achieve fast and reproducible #AAV titer using validated assay cartridges on an automated #ELISA platform • See how to pair molecular weight information with analytical grade #immunoassay quantitation • Understand how a multi-attribute analytical tool can assist in unraveling critical quality attributes from development through QC release Watch at your convenience below:

👋 Hope to see you at Vitalis in May. I will give a talk on AI and share detailed insights into the most interesting early-stage life science projects in the Nordic region and how AI connects life science and technology. These early stage companies, together with the existing ecosystem, will play a significant role in shaping the future of healthcare. A clear trend is that the boundaries between pharmaceuticals, medical technology, and e-health are gradually fading. Two particularly interesting additions to the matrix are AI and advanced materials, which, when combined, create impressive technological leaps. Pin Tuesday May 14, 2024 14:30 in your cal 😊 Scale Up Life Science Invest, magnus klaesson, Ann-Charlotte Beckman, Nasim Bergman Farrokhnia, Gunilla Englund, Karina Tellinger McNeil, Daniel Forslund, Boel Mörck, Mikael Hoffmann, Karin Gårdmark Östh, Björn Arvidsson

Grateful for the opportunity to participate in the 2024 CAP TODAY Urinalysis Roundtable. It was both a critical and illuminating discussion on the current state of testing. The future is bright for urinalysis as Siemens Healthineers and clinical laboratory leaders aim to overcome challenges and expand in-vitro diagnostic opportunities through tools such as digitalization and AI! Read now. https://lnkd.in/e_fuqsx5